Watch CARL. Know when insiders buy.
One email the day a filing lands. Free.
CARL
CARLSMED, INC.
14.99
−0.24 −1.58%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
61
WATCH · shorts 61
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $409.3MP/E —DIV YIELD —FCF YIELD -8.45%REV TTM —NET INCOME −$36.3MNET CASH $30.9M52W 8.83 – 16.99SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$11M | −$10.5M | — | -0.39 | −$7.4M | $121K | −$7.5M | Aug 5 |
| Q1 2026 · Mar 31 | — | — | — | −$9.3M | −$8.7M | — | -0.32 | −$13M | $79K | −$13.1M | Aug 5 |
| Q4 2025 · Dec 31derived | — | — | — | −$9.3M | −$8.6M | — | 0.03 | −$5.3M | $73K | −$5.4M | Feb 25 |
| Q3 2025 · Sep 30 | — | — | — | −$9M | −$8.5M | — | -0.40 | −$8.5M | $159K | −$8.6M | Nov 6 |
| Q2 2025 · Jun 30 | — | — | — | −$6.5M | −$6.8M | — | -1.47 | −$7M | $327K | −$7.4M | Aug 5 |
| Q1 2025 · Mar 31 | — | — | — | −$5.7M | −$5.7M | — | -1.47 | −$8.2M | $83K | −$8.2M | Aug 5 |
| Q4 2024 · Dec 31derived | — | — | — | −$4.7M | −$4.7M | — | -1.14 | −$4.2M | $61K | −$4.3M | Feb 25 |
| Q3 2024 · Sep 30 | — | — | — | −$7.8M | −$7.8M | — | -2.06 | −$7.6M | $52K | −$7.6M | Nov 6 |
| Q2 2024 · Jun 30 | — | — | — | −$6.3M | −$6.3M | — | -1.55 | — | — | — | Nov 6 |
| Q1 2024 · Mar 31 | — | — | — | — | −$5.4M | — | — | — | — | — | Nov 6 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$30.6M | −$29.6M | — | -2.12 | −$29M | $642K | −$29.6M | — | — |
| FY2024 · to Dec 31 | — | — | −$24.1M | −$24.3M | — | -6.11 | −$25.5M | $180K | −$25.6M | — | — |
Every number comes from CARLSMED, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.